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Due to our observations that eIF2α phosphorylation was mediated via PKR, we speculated 1 7 3 that inhibition of PKR activity would restore the repression of host cell protein translation. Following MNV infection and C16 treatment, cells were incubated with puromycin before 1 7 5 harvesting lysates at 12 or 15 hpi. Similar to previous results, protein translation is severely 1 7 6
inhibited in the untreated MNV-infected cells, however surprisingly this phenotype was also 1 7 7 maintained even in the presence of C16 and the lack of p-eIF2α ( Fig. 2B ). Thus, our results indicate 1 7 8 that MNV-induced repression of host translation is uncoupled and independent of a PKR and p-1 7 9
eIF2α-mediated mechanism and must occur via a different regulatory pathway. Previous studies have suggested that the MNV protease NS6 can influence host cell protein PABP-GFP expression was still observed (Fig. S1A ). Further, we co-transfected cDNA expression 1 8 7 plasmids encoding MNV NS3, NS6 or NS7 (RdRp) with PABP-GFP in HEK 293T cells. Upon co- To test if the translation of these major cytokines is affected by the global host translation 2 1 8
shutoff during MNV infection, we infected RAW 264.7 cells with MNV, treated them with 2 1 9
Poly(I:C) and the secretion inhibitor Brefeldin A (BFA), or left them untreated (Fig. 4B ). Cell 2 2 0 culture supernatant samples were harvested at 9, 12 and 15 h.p.i and cytokine secretion was were similar to Poly(I:C) and BFA treated cells suggesting that secretion might be inhibited, infected macrophages ( Fig. S2) , indicating that the reduction in protein levels is likely related to our 2 3 0 observed MNV-induced translational inhibition. One of the control mechanisms for translation of interferon stimulated genes (ISGs) and To determine if MNV interferes with SG formation, cells were treated with NaAs and 2 4 5 subsequently infected with MNV for 12 hrs (Fig. 5A , panels J-L). We observed an inhibitory effect 2 4 6 of MNV on the amount of NaAs-induced SGs (Fig. 5A , panels J-L) compared to NaAs-treated 2 4 7 uninfected cells (Fig. 5A , panels G-I). In NaAs treated and MNV-infected cells exhibiting SG 2 4 8 formation, the morphology of SGs was smaller and elongated, instead of having a typical, round-2 4 9
shaped appearance ( Fig. 5A , panels J-L). To quantitate the changes observed, we determined the protease-mediated cleavage of G3BP1 and other accessory proteins (49). To determine if this was 2 6 0 also true for MNV infection, we investigated the protein levels of eIF3 , G3BP1 and TIA-1 by 2 6 1 WB. To this end, we observed no significant change in the total protein levels or size of any of 2 6 2 these proteins as infection progressed, indicating that MNV does not manipulate SG formation 2 6 3 through protease-mediated cleavage of key SG proteins ( Fig 5D) . These results suggest that MNV To examine the ability of MNV to prevent SG induction we visualised the distribution and 2 7 0 abundance of key SG nucleating proteins eIF3 and G3BP1 by IF analysis in MNV-infected BMM 2 7 1 cells ( Fig. 6 ). We observed no significant altered distribution of eIF3 in MNV-infected cells, 2 7 2 either at the sites of viral replication or to discrete cytoplasmic foci ( Fig. 6A , i compared to a). In replication as identified with antibodies to the MNV VPg protein (NS5) ( Fig. 6A , j compared to b). The sequestering of G3BP1 also occurred in MNV-infected cells that were additionally treated with 2 7 6 NaAs ( Fig. 6A , n compared to f). As we had observed that G3BP1 had been sequestered within the MNV RC, we aimed to G3bp1 gene and suppression of G3BP1 expression was assessed by WB analysis. siRNA-mediated 2 8 5 treatment resulted in a reduction of the G3BP1 protein ( Fig. 6B ). Upon subsequent infection of 2 8 6 these cells we observed an attenuation in MNV replication, by WB (NS7) ( Fig. 6B ) and the 2 8 7 production of infectious virus, as assessed by plaque assays where virus titres with a 1-1/2 logs 2 8 8 reduction (representing an ~90-95% decrease in infectious virus) were observed ( Fig. 6C ). To further examine the impact of G3BP1 on MNV replication, we knocked out G3BP1 2 9 0 expression in BV2 cells via CRISPR-Cas9 (G3BP1-KO). In G3BP1-KO BV2 cells, we re-2 9 1 introduced G3BP1 by transfecting wild type mouse G3BP1 (WT-mG3BP1) and two mG3BP1 2 9 2 1 3 deletion mutants: mG3BP1-∆RGG (∆RGG; deletion of the co-operative RNA binding domain 2 9 3 (RGG) from aa408-465) and mG3BP1-∆RRMRGG (∆RRMRGG; additionally includes RNA-2 9 4 binding domain (RRM) from aa340-407) as well as an empty vector ( Fig. 6D and E). We infected 2 9 5 these cells with MNV and collected virus containing tissue culture fluid at 12 and 24 h.p.i to 2 9 6 measure viral titres. In WT-BV2 cells, peak virus replication (10 7 PFU/mL) was observed after 12 2 9 7 h.p.i and this level remained steady until 24 h.p.i (Fig. 6E , blue line). Consistent with our siRNA 2 9 8 results, knockout of G3BP1 resulted in the complete abolishment of virus replication, highlighting 2 9 9
the importance of G3BP1 for MNV replication (Fig. 6E , green line). Interestingly, the re- Based on these observations we suggest that the recruitment of G3BP1 to the MNV RC is G3BP1contributes to MNV replication, however we would speculate that it contributes to binding 3 0 9
of the MNV viral RNA perhaps to stabilise some protein-RNA interactions. It is important to note 3 1 0 that sequestration of G3BP1 is also critical to prevent SG formation and promote viral replication 3 1 1 without interference of the innate immune response. The shutdown of host cell translation is one of the major host defence mechanisms against their own translational machinery and parasitise the hosts. Therefore, a reduction in host protein 3 1 7 1 4 translation will likely lead to a decreased translation of viral proteins and interfere with efficient intracellular amounts of NS7 increase from 6 hpi onwards, while host protein translation subsides 3 2 1 (Fig. 1B) . These observations strongly suggest that MNV employs an alternative mechanism to 3 2 2 initiate translation, independent of cellular protein translation (51). The HuNoV and MNV VPg MNV proteins, which is independent of the cellular cap-dependent protein translation, could be translation (54). This would be a great advantage for the virus, not only by forcing the cell to 3 2 8
preferentially translate viral proteins, but also by diminishing the innate immune response by 3 2 9
preventing the translation of immune effectors such as cytokines.
To uncover how MNV manipulates the ISR, we investigated the PKR/eIF2α pathway, which 3 3 1 is a major regulator of the ISR (Fig 1, 2 and 3 ). We demonstrated that MNV infection leads to the (from 9 hpi), indicating a reduction in global host cell translation (Fig. 1B) . Based on the 3 3 7
immunoblot and IF analysis (Fig. 1C) , MNV starts to affect host cell translation from 9 hpi, 3 3 8 reducing host cell translation to a minimum in most infected cells by 12 hpi (Fig. 1C ). Expression studies of single viral proteins revealed that NS3 expression alone is sufficient to induce translation 3 4 0 inhibition (Fig. 3) . We presumed that p-eIF2α may be regulated via PKR which is activated by binding to 3 4 2 dsRNA produced during MNV infection. We initially showed that phosphorylation of eIF2α was 3 4 3 mediated via PKR rather than PERK (Fig 2) . Interestingly though, when cells were treated with C16 3 4 4
and analysed for their translation activity via puromycin treatment, we did not observe an increase by MNV is effective and robust ( Fig. 3 ) and we show that it affects the translation of innate immune 3 4 9
response regulators like cytokines (Fig. 4 ).
3 5 0
The release of cytokines such as IFNβ, TNFα and IL-6 during viral infections plays a crucial neighbouring cells or to receptors on the infected cell itself to enhance the antiviral response (55).
3 5 5
We and others have shown that MNV infected cells increase the transcription of cytokine (IFNβ, 3 5 6
TNFα and IL-6) mRNAs ( Fig. 4) the acute infection ( Fig. 4) . Our subsequent studies revealed that the low amounts of secreted 3 6 0 cytokines from infected cells were not due to the inhibition of general protein secretion (Fig. S2 ).
6 1
Instead, we observed that only very low amounts of translated cytokines can be detected within the 3 6 2 infected cells, further confirming that there is no secretion inhibition, which would cause the 3 6 3 accumulation of cytokines within the cells (Fig. 4) . The difference in intracellular protein levels for TNFα compared to the mRNA levels indicates an interference of the virus with either protein 3 6 5 stability or the translation of host cell proteins. formation, which is part of the ISR, generates cytoplasmic granules containing stalled translational 3 7 0 machineries involved in regulating RNA transcript homeostasis (59). This mechanism serves as an cellular stresses including ER stress, oxidative stress, heat shock (60, 61) and viral infection (59). Under stressed conditions, cells activate eIF2α kinases to phosphorylate eIF2α which depletes the 3 7 5 eIF2α-GTP-tRNA met ternary complex required to form the preinitiation complex, resulting in 3 7 6 stalled translation initiation (31, 32). These stalled preinitiation complexes aggregate and form SGs, selectively control RNA translation, and therefore promote their replication (Reviewed in 28, 62).
8 0
Previous studies have shown that many different virus families modulate SG function to In fact, when cells are treated with NaAs, MNV infection significantly dampened SG formation and 3 8 5
SGs that were present had atypical morphologies and reduced SG numbers ( Fig. 5A and B) . These their study potentially identifying subtle cell type differences. We have shown that MNV recruits G3BP1 to sites of viral replication (Fig. 6A) recruitment to the assembly complex seems to serve a dual purpose, i) the promotion of viral Based on our findings, MNV likely employs a strategy similar to picornaviruses and complexes containing essential components of the translational machinery (Fig. 7, model) . It is 4 0 7
intriguing to speculate that MNV selectively induces cap-dependent translation inhibition to 4 0 8 enhance viral translation and inhibit the innate immune response but needs access to the 4 0 9
translational machinery and therefore inhibits SG formation. This strategy not only increases viral 4 1 0 replication efficiency, but also promotes immune evasion of the virus, which could explain the 4 1 1 rapid replication cycle and the delayed innate immune response to MNV infection. were cultivated at 37°C in a 5% CO 2 incubator, as previously described (19). of infection (MOI) of 5, as previously described (19). Cells were rocked in a low volume of media 4 2 3
for one hour at 37 °C, before cells were supplemented with additional media. Unless indicated 4 2 4 differently, cells were fixed or lysed at 12 h.p.i. If supernatant was collected, the media was 4 2 5 centrifuged at 10,000g for 3 min to pellet cellular debris. Sodium arsenite (Sigma-Aldrich) was added to cells at a concentration of 250 µM for 20 4 2 8 mins prior to fixation or cell lysate collection. The PKR inhibitor C16 (Sigma-Aldrich) was added 4 2 9
to infected cells at a concentration of 1 µM at 1 h.p.i and cell lysates were collected 12 h.p.i. The was added to cells at a concentration of 10 µg/ml at indicated times prior to cell lysate collection.
3 2
Goat anti-eIF3η, Goat anti-G3BP1 and Goat anti-TIA-1 were all purchased from Santa Cruz Biotech. Rabbit anti-eIF2α was purchased from Invitrogen; Rabbit anti-actin from Sigma-Aldrich; Rabbit anti-NS5 were manufactured and produced by Invitrogen. with water and plaque formations were enumerated. and MilliQ water and mounted on cover-slides with ProLong Diamond (Life Technologies). Cells were analysed using the Zeiss LSM710 confocal microscope. Illumina HiSeq. BV2 cells are polyploid at the G3BP1 locus as described previously (PMID: resulted in frame shifts and the absence of detectable G3BP1 protein as measured by WB.
0 6
Sequences are available upon request. Wilen, Jason M. Mackenzie and immunolabelled with anti-NS7, anti-p-eIF2α, anti-puromycin and anti-calnexin antibodies. 
